LEARNING OBJECTIVES

1. Describe the principles underlying measurable residual disease detection (MRD) in AML using flow cytometry.
2. Compare the relative merits of MRD detection using molecular based methods and flow cytometry in AML.
3. Recognize the prognostic significance of MRD in AML.
4. List potential pitfalls in MRD analysis in AML using flow cytometry.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.